W. Ruka - Concepedia

Author

W. Ruka

The Maria Sklodowska-Curie National Research Institute of Oncology

Also Known As

Ruka Włodzimierz, W Ruka, W. Ruka, WLODZIMIERZ RUKA, Wlodzimierz Ruka, Włodzimierz Ruka

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology KU Leuven Gdańsk Medical University Medical University of Warsaw Jagiellonian University

About

W. Ruka is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.6K
2	Gastroenterology	5	5	462
3	Health Sciences	2	2	94
4	Engineering	1	1	31
5	Immunology	1	1	310

W. Ruka

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials Piotr Rutkowski, M. van Glabbeke, Cathryn Rankin, Journal of Clinical Oncology	2010	398
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience Natale Cascinelli, Filiberto Belli, Mario Santinami, Annals of Surgical Oncology Dermoscopic ImageSurgical PathologyMelanomaCutaneous MelanomaDermatology	2000	332
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial Alexander M.M. Eggermont, Stefan Suciu, Rona M. MacKie, The Lancet Surgical OncologyOncologyMelanomaImmunologyClinical Trials	2005	310
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor Piotr Rutkowski, Zbigniew Nowecki, Wanda Michej, Annals of Surgical Oncology Prognostic FactorsSurgical OncologyGastrointestinal OncologyRisk CriteriaColorectal Surgery	2007	265
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. V. Bramwell, Jacques Rouëssé, William P. Steward, Journal of Clinical Oncology	1994	249
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate Piotr Rutkowski, Zbigniew Nowecki, Paweł Nyckowski, Journal of Surgical Oncology	2006	186
Increased cancer risk of heterozygotes with <i>NBS1</i> germline mutations in poland Jan Steffen, Raymonda Varon, Maria Mosor, International Journal of Cancer	2004	126
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis Piotr Rutkowski, Janina Kamińska, M Kowalska, Journal of Surgical Oncology	2003	115
Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma Zbigniew Nowecki, Piotr Rutkowski, Anna Nasierowska‐Guttmejer, Annals of Surgical Oncology Dermoscopic ImageMedicineSurgical PathologyMelanomaPathology	2006	99
Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis Piotr Rutkowski, Janina Kamińska, M Kowalska, International Journal of Cancer	2002	99

Page 1